Reply to: Insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma

Surgery. 2019 Mar;165(3):664-667. doi: 10.1016/j.surg.2018.10.019. Epub 2018 Nov 19.

Authors

Jan Franko¹, Sarah McAvoy²

Affiliations

¹ Department of Surgery. Mercy Medical Center, Des Moines, IA, USA.
² Department of Radiation Oncology. Mercy Medical Center, Des Moines, IA, USA.

PMID: 30467040
DOI: 10.1016/j.surg.2018.10.019

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Squamous Cell / surgery*
Esophageal Neoplasms / surgery*
Esophageal Squamous Cell Carcinoma*
Esophagectomy
Humans
Lymph Nodes
Neoadjuvant Therapy